 Participants who completed 24 months of the base study were invited to continue in three extensions: MK0822-004-10, which extended the study to 36 months, MK0822-004-20 NCT00112437 which extended the study to 60 months, and MK0822-004-30 NCT00112437, which extended the study to 120 months. 